$1.1 Million EBITDA, Electrotherapy TENS Device Company in Texas
Texas TENS Device Company Delivers 1.1M EBITDA and 38 Percent Margin
On NextCompany since August 27, 2026 (today)
TX area
Business overview
A medical device company in Texas produces non-invasive electrotherapy products. Electrodes comprise 90 percent of its product mix. The company maintains a physician and therapist referral network. Revenue grew at an 84 percent CAGR over three years. 2026 revenue is forecast at 2900000 dollars. Adjusted EBITDA for 2026 reaches 1100000 dollars. The team of eight employees and seven contractors is expected to remain. The seller will consider rollover equity.
Who is a good fit for this business
- Medical device acquirers with referral network experience pursue this Texas operation.
- Buyers open to rollover equity structures evaluate this electrotherapy company.
- Strategic investors targeting 38 percent EBITDA margins consider this device maker.
Details
Frequently Asked Questions
Electrodes account for 90 percent of the product mix. TENS devices represent 5 percent. Braces make up the remaining 5 percent.
The company forecasts 2900000 dollars in 2026 revenue. Adjusted EBITDA is projected at 1100000 dollars. The 38 percent margin reflects prior trends.
Eight employees are expected to remain. Seven independent contractors will also stay. The seller will consider rollover equity.
Revenue grew at an 84 percent CAGR over three years. Adjusted EBITDA margin stands at 38 percent.